Back to Search
Start Over
Study shows RegeneRx's Tss4 promotes autophagy and repair in chronic granulomatous disease model
- Source :
- PharmaBiz. November 16, 2019
- Publication Year :
- 2019
-
Abstract
- RegeneRx Biopharmaceuticals, Inc, a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced the publication of a new scientific study demonstrating how Thymosin beta 4 (Tss4) promotes [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.605916262